日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study

EGFR突变型非小细胞肺癌患者序贯阿法替尼联合奥希替尼与阿法替尼联合化疗的真实世界疗效：台湾多中心GIANT研究

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-026-01203-6
Ko, How-Wen; Liao, Ying-Ting; Liang, Sheng-Kai; Huang, Yen-Hsiang; Lin, Yu-Ching; Liu, Ping-Chi; Wang, Chin-Chou; Tsai, Jeng-Shiuan; Chen, Yuh-Min; Shih, Jin-Yuan; Yang, Tsung-Ying; Yang, Chang-Ta
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2026
文献求助 收藏

Dacomitinib as a First-Line Therapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational Study

达克替尼作为一线疗法治疗无脑转移的晚期EGFR突变非小细胞肺癌：一项多中心回顾性观察研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71659
Hsu, Ping-Chih; Ko, How-Wen; Chiu, Li-Chung; Huang, Shih-Hao; Lee, Chung-Shu; Lin, Yu-Ching; Kuo, Scott Chih-Hsi; Ju, Jia-Shiuan; Wang, Chin-Chou; Yang, Cheng-Ta
肺癌
肿瘤
肿瘤免疫
EGF
神经科学
EGFR
细胞生物学
发表日期：2026
文献求助 收藏

Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer

后续治疗对EGFR突变型非小细胞肺癌转化为小细胞肺癌患者临床结局的影响

期刊:Lung Cancer: Targets and Therapy
影响因子:3.3
doi:10.2147/LCTT.S516527
Chen, Ching-Yi; Ko, How-Wen; Hu, Po-Wei; Chang, Cheng-Yu; Chen, Chung-Yu; Chang, Shih-Chieh; Chiu, Yu-Chi; Wei, Yu-Feng
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Baseline and changes in inflammatory parameters for patients with EGFR-mutated NSCLC treated with afatinib

接受阿法替尼治疗的 EGFR 突变型非小细胞肺癌患者的基线炎症参数和炎症参数变化

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15338
Chang, Zi-Ting; Hsu, Ping-Chih; Ko, How-Wen; Chang, John Wen-Cheng; Wu, Chen-Te; Huang, Chen-Yang; Chang, Ching-Fu; Kuo, Chih-Hsi Scott; Yang, Cheng-Ta; Wu, Chiao-En
肺癌
肿瘤
炎症
肿瘤免疫
炎症/感染
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Sesamin induces cell cycle arrest and upregulation of NKG2D ligands in MG‑63 cells and increases susceptibility to NK cell cytotoxicity.

芝麻素可诱导 MG63 细胞的细胞周期停滞和 NKG2D 配体的上调，并增加其对 NK 细胞细胞毒性的敏感性

期刊:Experimental and Therapeutic Medicine
影响因子:2.3
doi:10.3892/etm.2025.12822
Chou Shou-Chu, Kuo Cheng-Yi, Ko How-Wen, Huang Pai-Tsang, Liu Chia-Hung, Wang Long-Siang, Liang Yao-Jen
细胞生物学
发表日期：2025
文献求助 收藏

Clinical outcome analysis of different first‑ and second‑generation EGFR‑tyrosine kinase inhibitors in untreated patients with EGFR‑mutated non‑small cell lung cancer with baseline brain metastasis.

对未经治疗的 EGFR 突变非小细胞肺癌伴基线脑转移患者进行不同的第一代和第二代 EGFR 酪氨酸激酶抑制剂的临床结果分析

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2025.14947
Hsu Chen-Chuan, Chiu Li-Chung, Ko How-Wen, Wu Chiao-En, Kuo Scott Chih-Hsi, Ju Jia-Shiuan, Huang Allen Chung-Cheng, Wang Chin-Chou, Yang Cheng-Ta, Hsu Ping-Chih
细胞生物学
肺癌
EGFR
肿瘤免疫
发表日期：2025
文献求助 收藏

Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study

尿镉浓度与 COVID-19 的严重程度和临床结局相关：一项双中心观察性队列研究

期刊:Environmental Health
影响因子:5.9
doi:10.1186/s12940-024-01070-6
Chiu, Li-Chung; Lee, Chung-Shu; Hsu, Ping-Chih; Li, Hsin-Hsien; Chan, Tien-Ming; Hsiao, Ching-Chung; Kuo, Scott Chih-Hsi; Ko, How-Wen; Lin, Shu-Min; Wang, Chun-Hua; Lin, Horng-Chyuan; Chu, Pao-Hsien; Yen, Tzung-Hai
发表日期：2024
文献求助 收藏

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

EGFR TKI治疗的晚期非小细胞肺癌中肿瘤和血浆T790M突变的差异性预后价值

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359231222604
Tung, Pi-Hung; Chiu, Tzu-Hsuan; Huang, Allen Chung-Cheng; Ju, Jia-Shiuan; Huang, Chi-Hsien; Wang, Chin-Chou; Ko, How-Wen; Chung, Fu-Tsai; Hsu, Ping-Chih; Fang, Yueh-Fu; Guo, Yi-Ke; Kuo, Chih-Hsi Scott; Yang, Cheng-Ta
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

抗程序性死亡配体1 (PD-L1) 免疫检查点抑制剂联合化疗治疗未经治疗的广泛期小细胞肺癌的临床分析

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines12050474
Hsu, Ping-Chih; Wu, Bing-Chen; Wang, Chin-Chou; Chiu, Li-Chung; Chang, Chiung-Hsin; Liu, Ping-Chi; Wu, Chiao-En; Kuo, Scott Chih-Hsi; Ju, Jia-Shiuan; Huang, Allen Chung-Cheng; Lin, Yu-Ching; Yang, Cheng-Ta; Ko, How-Wen
Checkpoint
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer

一线阿法替尼治疗晚期表皮生长因子受体突变型非小细胞肺癌患者延长无进展生存期的相关因素

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15212
Chiu, Li-Chung; Hsu, Ping-Chih; Wang, Chin-Chou; Ko, How-Wen; Kuo, Scott Chih-Hsi; Ju, Jia-Shiuan; Tung, Pi-Hung; Huang, Allen Chung-Cheng; Yang, Cheng-Ta
肺癌
肿瘤
肿瘤免疫
信号转导
细胞生物学
发表日期：2024
文献求助 收藏